KAISER FOUNDATION HOSPITALS - ANALYSIS TO EVALUATE THE EFFECTIVENESS OF A SEROGROUP B OUTER MEMBRANE VESICLE MENINGOCOCCAL VACCINE AGAINST GONORRHEA

PIID: 75D30121P11283
Effective Date: Aug 13, 2021End Date: Closed on Aug 12, 2022
Award $
$200K
Vendor
KAISER FOUNDATION HOSPITALS
NAICS
518210

Key Details

Dollars Obligated
$200,350
Awarding Sub-Agency
Centers for Disease Control and Prevention
NAICS Code
518210
Place of Performance
CA

Description

ANALYSIS TO EVALUATE THE EFFECTIVENESS OF A SEROGROUP B OUTER MEMBRANE VESICLE MENINGOCOCCAL VACCINE AGAINST GONORRHEA

Context & Analysis

Department of Health and Human Services obligated $200,350 to KAISER FOUNDATION HOSPITALS for analysis to evaluate the effectiveness of a serogroup b outer membrane vesicle meningococcal vaccine against gonorrhea. The award is classified under NAICS 518210. Performance is located in CA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 518210 — related awards are listed below.

Contractor Information

UEI: P1RTMASB37B5

Stay Updated

Get notified about new opportunities matching your interests.

Related